Bulltick Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$320K Buy
7,509
+691
+10% +$30.9K 0.07% 105
2026
Q1
$328K Buy
+6,818
New +$318K 0.07% 106
2025
Q1
Sell
-20,000
Closed -$965K 141
2024
Q4
$965K Hold
20,000
0.22% 73
2024
Q3
$1.15M Sell
20,000
-40,000
-67% -$2.16M 0.28% 67
2024
Q2
$2.91M Sell
60,000
-52,467
-47% -$2.53M 0.72% 41
2024
Q1
$5.47M Buy
+112,467
New +$5.49M 0.94% 40

Other funds holding SNY

Bulltick Wealth Management's SNY Position: Q2 2026 in Review

Bulltick Wealth Management increased its Sanofi (SNY) stake by 10% in Q2 2026, buying an estimated $30.9K and bringing the position to 7,509 shares worth $320K. The position accounts for 0.07% of the portfolio, ranked #105.

Bulltick Wealth Management first reported a position in SNY in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.47M in Q1 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Bulltick Wealth Management held 7,509 shares of Sanofi worth $320K as of Q2 2026.
  • Bulltick Wealth Management bought 691 Sanofi shares in Q2 2026, an estimated $30.9K.
  • Sanofi made up 0.07% of Bulltick Wealth Management's portfolio in Q2 2026, its #105 holding.
  • Bulltick Wealth Management first reported a position in Sanofi in Q1 2024 and has held it in 6 quarters since.
  • Bulltick Wealth Management's Sanofi position peaked at $5.47M in Q1 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Bulltick Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.